+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Analgesics in Japan

  • PDF Icon

    Report

  • 28 Pages
  • October 2023
  • Region: Japan
  • Euromonitor International
  • ID: 221582
Sales of analgesics in Japan have seen solid growth in current value terms in 2023 backed by increased opportunities for consumers to go out, the recovery in the number of inbound tourists, and a move away from the practice of wearing face masks on a daily basis. Nonetheless, it is important to note that while overall sales of analgesics are seeing solid growth this is being driven almost entirely by the recovery of topical analgesics/anaesthetic.

The Analgesics in Japan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the Analgesics market
  • Pinpoint growth sectors and identify factors driving change
  • Understand the competitive environment, the market’s major players and leading brands
  • Use five-year forecasts to assess how the market is predicted to develop

Table of Contents

ANALGESICS IN JAPANKEY DATA FINDINGS
2023 DEVELOPMENTS
  • Mixed fortunes for analgesics in 2023 with topical analgesics/anaesthetic being key to growth
  • Salonpas benefits from rebound in demand for topical analgesics/anaesthetic, while Loxonin S continues to make waves
  • Players focus on adding value to their product lines
PROSPECTS AND OPPORTUNITIES
  • Stable outlook for analgesics with challenges and opportunities presenting themselves
  • New product development expected to focus on treating the causes of pain and stiffness
  • Players will need to address negative image issues to maintain demand
CATEGORY DATA
  • Table 1 Sales of Analgesics by Category: Value 2018-2023
  • Table 2 Sales of Analgesics by Category: % Value Growth 2018-2023
  • Table 3 NBO Company Shares of Analgesics: % Value 2019-2023
  • Table 4 LBN Brand Shares of Analgesics: % Value 2020-2023
  • Table 5 Forecast Sales of Analgesics by Category: Value 2023-2028
  • Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2023-2028
CONSUMER HEALTH IN JAPAN
EXECUTIVE SUMMARY
  • Consumer health in 2023: The big picture
  • 2023 key trends
  • Competitive landscape
  • Retailing developments
  • What next for consumer health?
MARKET INDICATORS
  • Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2018-2023
  • Table 8 Life Expectancy at Birth 2018-2023
MARKET DATA
  • Table 9 Sales of Consumer Health by Category: Value 2018-2023
  • Table 10 Sales of Consumer Health by Category: % Value Growth 2018-2023
  • Table 11 NBO Company Shares of Consumer Health: % Value 2019-2023
  • Table 12 LBN Brand Shares of Consumer Health: % Value 2020-2023
  • Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2018-2023
  • Table 14 Distribution of Consumer Health by Format: % Value 2018-2023
  • Table 15 Distribution of Consumer Health by Format and Category: % Value 2023
  • Table 16 Forecast Sales of Consumer Health by Category: Value 2023-2028
  • Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2023-2028
APPENDIX
  • OTC registration and classification
  • Vitamins and dietary supplements registration and classification
  • Self-medication/self-care and preventive medicine
  • Switches
DISCLAIMERDEFINITIONS
SOURCES
  • Summary 1 Research Sources